Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Jeffrey Hardacre, MD

Jeffrey Hardacre, MD

  • Chair, Surgical Oncology Quality Committee, UH Cleveland Medical Center
  • Professor, CWRU School of Medicine
  • Specialty: Surgical Oncology, General Surgery
  • Location:
    UH Minoff Health Center
    3909 Orange Pl
    Beachwood, OH 44122

Biography: Jeffrey Hardacre, MD

Expertise

  • Biliary Surgery
  • Gallbladder Surgery
  • Gastric Surgery
  • Gastrointestinal Surgery
  • Pancreatic Surgery
  • Surgical Oncology

Certifications & Memberships

  • Surgery - American Board of Surgery

Education

Fellowship | Endoscopy - Advanced
Endoscopy - Advanced - Cleveland Clinic (2003 - 2004)

Fellowship | Gastrointestinal Surgery
Gastrointestinal Surgery - Johns Hopkins University (2002 - 2003)

Residency | General Surgery
General Surgery - Johns Hopkins Hospital (1996 - 2002)

Medical Education
Duke University School Of Medicine (1992 - 1996)

Undergraduate
University Of Wisconsin-Madison (1992)

About

Jeffrey M. Hardacre, MD, FACS, is a surgeon in the University Hospitals Seidman Cancer Center. He sees patients at UH Cleveland Medical Center in Cleveland, Ohio, and UH Chagrin Highlands Health Center in Orange, Ohio. He operates at UH Cleveland Medical Center. Dr. Hardacre is a Professor of Surgery at Case Western Reserve University School of Medicine.

Dr. Hardacre is board certified in surgery. His clinical interests include cancers of the pancreas, stomach, bile duct, gallbladder and intestine. He also provides surgical care for benign diseases of the pancreas, including cysts and pancreatitis, and performs abdominal general surgery. Dr. Hardacre was named to the UH Seidman Cancer Center medical staff in 2004.

Dr. Hardacre earned his undergraduate degree in molecular biology from the University of Wisconsin-Madison, where he was elected to Phi Beta Kappa, and his Doctor of Medicine degree from Duke University School of Medicine in Durham, North Carolina, where he was elected to Alpha Omega Alpha. He completed his residency in general surgery and a surgical research fellowship at The Johns Hopkins Hospital in Baltimore, Maryland. He also completed advanced specialty training in gastrointestinal surgery at Johns Hopkins.

An active researcher, Dr. Hardacre is principal investigator at UH of a study examining a novel drug that targets mitochondria in pancreatic cancer cells. Dr. Hardacre has published more than 40 scientific papers in leading professional journals and is the author of multiple chapters in surgical textbooks. In addition, he is an active participant in national medical meetings, presenting abstracts, posters and invited lectures.

Dr. Hardacre is a fellow of the American College of Surgeons and member of the Society for Surgery of the Alimentary Tract, the Midwest Surgical Association, the Pancreas Club and the Central Surgical Association. In addition, he is a reviewer for the surgical journals Surgery, Annals of Surgery, Journal of the American College of Surgeons, and American Journal of Surgery.

Featured Videos

Watch to find out more about this University Hospitals physician.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Jeffrey Hardacre did not disclose any Outside Relationships with Industry.